LiveNSE delayed · 128/128 · 20 Aug 2026, 10:00 am
Scores stay the 15 Aug 2026 desk snapshot. Not advice.
POLYMED · Healthcare · Small Cap · Live 20 Aug 2026, 09:59 am · Discovery

Poly Medicure Ltd

Consumable medical-devices exporter with high ROCE and a broadening SKU book. Quiet compounder.

10X Low
Low Risk
Attractive Entry
Compounder
Institutional Accumulation
Multibagger score
60.5/100
Market cap
₹17,946 Cr
Last price · live
₹1,777.2
+6.90 (+0.39%)
52W
₹1,182–₹2,145

Implied P/E 52.1x · POLYMED.NS · delayed NSE

10X potential (scenario)
LOW
Base multiple
1.9x
Bull multiple
3.5x
Classification
Potential Mid Cap

Base case compounds into a durable mid-cap, not yet large-cap scale.

Final investment scorecard

Multibagger60.5 / 100
10X potentiallow
Business quality6.1 / 10
Growth runway6.7 / 10
Competitive advantage6.8 / 10
Management7.7 / 10
Balance sheet7.8 / 10
Valuation2.6 / 10
Technical setup8.2 / 10
Risklow

Why it could become a multibagger

  • Clean export compounder still taking global share.
  • Cash conversion supports self-funded plants.

What needs to go right

  • New plant utilisation
  • SKU mix premiumises
  • Domestic hospital formalisation

What could destroy the thesis

  • A quality recall
  • Sustained tender price war

What would make me sell

  • A material recall
  • ROCE < 14%

Key metrics to monitor

Export mix
Gross margin
ROCE
FCF
New-plant utilisation

Illustrative FY25 / TTM desk snapshot compiled for this terminal. Not a live NSE/BSE feed. Cross-check annual reports, exchange filings and investor presentations before use.